Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oswald A Stuart

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Oncology Nursing Forum|January 22, 2005
Avoiding carcinogen exposure with intraperitoneal paclitaxelOswald A Stuart, Claudette Knight, Paul H Sugarbaker
Cancer Journal (Sudbury, Mass.)|June 27, 2009
Pharmacokinetics and pharmacodynamics of perioperative cancer chemotherapy in peritoneal surface malignancyKurt Van der Speeten, Oswald A Stuart, Paul H Sugarbaker
Journal of Translational Medicine|April 12, 2006
Perioperative intraperitoneal chemotherapy for peritoneal surface malignancyTristan D Yan, Oswald A Stuart, Dal Yoo, et al.
Recent Patents on Anti-Cancer Drug Discovery|June 13, 2009
Rationale for an intraperitoneal gemcitabine chemotherapy treatment for patients with resected pancreatic cancerAnil Kamath, Dal Yoo, Oswald A Stuart, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Oncology Nursing Forum|January 22, 2005
Avoiding carcinogen exposure with intraperitoneal paclitaxelOswald A Stuart, Claudette Knight, Paul H Sugarbaker
Cancer Journal (Sudbury, Mass.)|June 27, 2009
Pharmacokinetics and pharmacodynamics of perioperative cancer chemotherapy in peritoneal surface malignancyKurt Van der Speeten, Oswald A Stuart, Paul H Sugarbaker
Journal of Translational Medicine|April 12, 2006
Perioperative intraperitoneal chemotherapy for peritoneal surface malignancyTristan D Yan, Oswald A Stuart, Dal Yoo, et al.
Recent Patents on Anti-Cancer Drug Discovery|June 13, 2009
Rationale for an intraperitoneal gemcitabine chemotherapy treatment for patients with resected pancreatic cancerAnil Kamath, Dal Yoo, Oswald A Stuart, et al.
Pageof 1